A University of Washington–led study found that Washington state’s hepatitis C elimination initiative significantly expanded access to testing and treatment while reducing costs per patient over time. Although total hepatitis C–related healthcare costs initially increased after the program launched in 2018, they later declined even as screening rates rose and more cases were identified. The initiative combined widespread screening, reduced barriers to care and discounted purchasing of antiviral medications, making treatment more accessible across the state. Researchers analyzed insurance claims…
Study shows Washington’s Hepatitis C plan boosted screening while cutting costs









